QRS after TAVI, The Best Predictor for safe transitory pacemaker removal

Original title: Patients Without Prolonged QRS After TAVI with CoreValve Device do not Experience High-Degree Atrio-Ventricular Block. Reference: Gauthier Mouillet et al. Catheterization and Cardiovascular Interventions 81:882–887 (2013).

High degree atrioventricular block (AVB) in the context of transcatheter aortic valve implantation (TAVI) has been reported with variable incidence (3-45%) depending on the population characteristics and the kind of prosthesis. This event happens immediately after TAVI only in 30% of cases, most of BAV being delayed within 7 days after implantation. The study aimed at prospectively identifying post TAVI delayed AVB predictors requiring permanent pacemaker (PP). 

104 TAVI patients were analyzed at one center between 2007 and 2011, with the CoreValve ReValving system (Medtronic, Northridge, CA). 14 patients that were not free from PP before TAVI indication and 11 patients that presented AVB immediately after TAVI were excluded; 79 patients made the final analysis. After implantation, 21 patients exhibited delayed high grade AVB (27%): 17 (80%) in the first week, 3 within 30 days and only one within 12 months. There were no significant differences in clinical baseline characteristics or ECG between those that required PP and those who did not.

Patients that developed delayed high grade AVB after TAVI presented wider QRS duration, greater prevalence of left branch block and deeper implantation; however, QRS duration immediately after TAVI was the sole independent predictor of delayed high degree AVB when performing a multivariable analysis. QRS width as predictor of delayed AVB and the resulting need of a PP had a 0.76 ROC area under the curve (p<0.001; 95% IC, 0.65-0.85) with best cut off at 148 msec, 64% sensitivity and 73% specificity. However, if cut off was lowered to 128 msec, we could achieve 100% sensitivity to predict the need of a PP, resigning some specificity. After a mean follow-up of 10 ± 8 months, patients with post-TAVI QRS ≤128 msec did not require a PP.

Conclusion: 

High degree atrioventricular block after TAVI generally requires a PP. QRS duration immediately after implantation was the best predictor of this event. Patients that presented post TAVI QRS ≤128 msec have no risk of high degree AVB block.

Editorial Comment: 

This precise cut off is relevant to the management of this patients given that a QRS ≤128 msec is not a safe indicator for transitory pacemaker early removal or for hospital discharge. On the other hand, greater duration QRS invites us to be cautious and wait longer to discharge patients, despite the fact that the patient may present optimal clinical conditions. 

SOLACI.ORG

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...